secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2025-12-08T23:59:59+00:00
Accession:  0001213900-25-119217
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio extends poison pill rights agreement to December 31, 2026
--------------------------------------------------------------------

- Amendment No. 5 to Rights Agreement dated Dec 5, 2025 extends expiration to Dec 31, 2026.
- Expiration date will auto-extend for successive one-year terms unless Board decides otherwise.
- Rights Agreement originally dated Dec 30, 2020 between INmune Bio and VStock Transfer LLC.
- No other changes to terms of the shareholder rights plan were disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025119217/0001213900-25-119217-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025119217/ea0268667-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-119217

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer